ADHD360 Press Release

Attention Deficit Hyperactivity Disorder (ADHD) constitutes one of the most prevalent childhood disorders. ADHD is characterized by persistent symptoms of inattention and/or hyperactivity-impulsivity, for at least 6 months in two or more settings, which have negative impact on functionality and development. The diagnosis is a multiparametric but not standardized procedure that includes clinical interview with parents and teachers, broadband and narrowband rating scales, functional behavioral analysis (FBA), neuropsychological evaluation, direct behavioral assessment as well as medical examination.  The existing interventions for ADHD and the assessment of their effectiveness are based on systematic behavioral recordings. Although systematic recordings provide useful information, they are often biased due to subjectivity.

In the framework of the Operational Program “Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH – CREATE – INNOVATE”, we will implement the project “ADHD360”.  The project will be co-financed by the European Union and Greek national funds.

The main objective of the program is the development a novel, integrated platform based on a serious game. The ADHD360 platform will have three core goals:

  • Discriminate ADHD from non-ADHD children
  • Use the serious game as an alternative intervention
  • Evaluate the effectiveness of the intervention on ADHD symptoms

The project is expected to have a significant impact on society, namely on parents and educators, health professionals and people diagnosed with ADHD.

The project “ADHD360” will be implemented by the Intelligent Systems Lab (School of Informatics), Lab of Medical Physics (School of Medicine) and the company The Second Method (TSM). The organizations involved have the required expertise in data analysis, machine learning methods, clinical trials, software development and gamification that will be incorporated in the project. The evaluation of the ADHD360 platform will be performed through clinical trials.

A newsletter subscription is available in the homepage, for those interested in receiving news and updates regarding the ADHD360 platform.

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top